查看購物車
  • Simplified Chinese
  • English
  • Japanese
封面
市場調查報告書
商品編碼
1840850

依動物類型、產品類型、通路、治療領域及給藥途徑動物用藥品市場－2025-2032年全球預測

Veterinary Medicine Market by Animal Type, Product Type, Distribution Channel, Therapeutic Area, Route Of Administration - Global Forecast 2025-2032
出版日期: | 出版商: 360iResearch | 英文 193 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

預計到 2032 年，動物用藥品市場規模將達到 839.1 億美元，複合年成長率為 7.94%。

關鍵市場統計數據
基準年 2024 455.1億美元
預計年份：2025年 491億美元
預測年份 2032 839.1億美元
複合年成長率 (%) 7.94%

為決策者提供一份簡潔的獸醫生態系統發展概況，重點在於綜合護理、預防策略和商業性要務。

動物用藥品產業正處於曲折點，技術創新、消費模式的改變以及監管環境的演變正在重塑臨床實踐、產品開發和分銷。本執行摘要簡要概述了高階領導者在應對短期挑戰和掌握長期策略機會時必須考慮的結構性促進因素、競爭動態和營運影響。

近年來，獸醫學已從單一治療轉向以預防為主、以診斷主導的決策和以數據主導的綜合動物健康管理。這一趨勢在伴侶動物照護領域尤其明顯，寵物飼主越來越重視便利性、數位互動和更高的照護標準。同時，在畜牧業和馬匹領域，對生物安全、生產力和飼料轉換率的日益關注也推動了產品組合和服務內容的轉變。

因此，企業領導者需要調整其研發重點、市場推廣模式和供應鏈韌性，以適應這些多領域的變革。本導言為後續章節奠定了框架，這些章節包括整個生態系統的轉型變化、2025年關稅相關貿易影響的預測、細分市場層面的考慮、區域動態、競爭定位、可操作的建議以及支撐我們研究結果的調查方法。本書有意整合了物種、產品、分銷、治療和給藥等方面的知識，旨在幫助相關人員將策略意義說明為切實可行的措施。

診斷主導護理、數位化管道和供應鏈本地化如何重塑獸醫學領域的產品開發和服務交付

一場根本性的變革正在改變動物保健服務的提供方式、產品的研發方式以及商業性價值的取得方式。更快速的照護現場診斷和先進的影像技術能夠實現早期療育，從而推動對標靶藥物和疫苗的需求。這些以診斷為驅動的模式正在重塑犬貓等伴侶動物的臨床通訊協定，同時也影響牛、家禽和豬等畜群的健康管理策略。

另一項變革性趨勢是數位醫療和遠距醫療模式的快速普及。遠端醫療和數位分診平台正成為傳統診所的有效補充，尤其是在都市區寵物市場和診所密度較低的地區。這些數位化能力正在改變分銷格局，為網路商店與藥房和獸醫診所合作提供一體化醫療服務創造了機會。它們還有助於更有效地管理各個治療領域的慢性疾病，例如抗感染藥感染疾病和抗發炎藥物。

供應鏈在地化和製造創新構成了第三大轉變。為因應地緣政治的不確定性和疫情帶來的教訓，企業正在加速投資本地化的配方和填充能力，以及針對當地情況量身定做的替代給藥途徑，例如注射劑、口服劑和外用劑。最後，對配方科學和新型疫苗平台的日益重視，例如針對特異性物種需求的重組疫苗（用於馬匹）和提高牲畜去活化疫苗的穩定性，正在改變產品開發藍圖和監管溝通策略。

評估2025年美國關稅對動物用藥品供應鏈、採購選擇和定價動態的策略影響

貿易政策變化和關稅會對動物用藥品價值鏈的投入成本、供應鏈策略和定價權產生重大影響。美國已實施或提案於2025年實施的關稅迫使製造商和經銷商重新評估其活性藥物​​原料藥、疫苗組成和診斷設備的籌資策略。這些關稅可能會增加進口原料和成品的到岸成本，促使企業評估供應商多元化、近岸外包和長期採購協議等方案。

隨著企業做出應對，物流和庫存策略也將隨之調整。企業將增加安全庫存或轉向多通路採購以降低風險敞口，而合約製造外包和經銷商將重新評估合約條款並提高風險分配的透明度。同時，定價紀律至關重要。企業必須考慮如何在成本回收和競爭定位之間取得平衡，尤其是在價格敏感的管道，例如網路商店和藥局。在存在替代品的治療領域，例如學名藥藥和品牌處方藥，關稅造成的成本差異可能會加速替代品的出現，或者相反，增強對國產品牌的需求。

監管和政策應對措施將進一步影響結果。政策制定者可以針對基本動物用藥品實施有針對性的豁免，以保護動物健康和食品安全，並透過稅額扣抵和津貼獎勵國內生產。因此，高階領導人應密切關注貿易政策的發展，同時與行業協會和監管機構合作，倡導建立可預測的貿易框架，以保護動物健康和該行業的韌性。

細分市場層面的策略指導，協調物種特定需求、產品模式、治療重點、分銷管道和給藥途徑，以做出更明智的決策。

細緻入微的市場區隔觀點對於將市場動態轉化為可執行的商業計劃至關重要。相關人員應根據動物類型，制定不同的策略，例如：伴侶動物市場（犬貓主導臨床需求和消費者支出）、馬匹市場（馬匹具有獨特的表現和健康需求）以及畜牧業市場（包括牛、雞和豬，規模、生物安全和飼料轉換率是產品推廣的關鍵因素）。每種動物類別都有不同的購買模式、監管節點和管道偏好。

按產品類型分類，可以發現不同的創新和商業化路徑。診斷產品包括影像學技術和感染疾病檢測，這些技術擴大應用於臨床第一線，從而影響下游藥物和疫苗的取得。藥用飼料添加劑旨在提高畜牧生產效率，需要與飼料生產商和農場管理系統密切合作。藥品包括學名藥、非處方藥和處方箋藥，每種藥品都面臨不同的監管負擔和利潤率。疫苗包括去活化疫苗、減毒活病毒疫苗疫苗和重組疫苗，需要專門的低溫運輸和給藥能力。

分銷管道細分——包括網路商店、藥局和獸醫診所——決定了客戶獲取模式和利潤結構。線上通路提供便利的購買方式和訂閱模式，藥局提供非處方藥零售，而診所則結合了診斷和照護現場治療。不同的治療領域——抗感染藥感染疾病、抗發炎藥物、循環系統藥物和抗寄生蟲藥物——決定了研發重點。抗感染藥感染疾病需要針對抗生素、抗真菌藥物和抗病毒藥物分別制定有針對性的管理策略。殺寄生蟲藥物分為體外殺寄生蟲藥物和體內殺寄生蟲藥物，二者的給藥方案各有不同。給藥途徑——吸入、注射、口服或外用——也會進一步影響產品設計、使用者訓練需求和市場接受度曲線。

區域動態和跨境因素影響著世界主要地區的監管協調、生產決策和分銷策略

區域動態對動物保健領域的管理體制、分銷架構和投資重點有顯著影響。動物用藥品。這些特點提高了都市區每隻動物的就醫支出，並為診斷和處方箋藥的銷售創造了有利的管道。相較之下，歐洲、中東和非洲地區（EMEA）呈現異質性，許多歐洲市場擁有先進的法律規範和高標準的獸醫體系，而中東和北非地區（MENA）的某些司法管轄區則將動物健康和生物安全置於優先地位，以保護食品供應鏈。

亞太地區獸醫服務正經歷快速現代化，製造業投資不斷成長，對伴侶動物和生產動物產品的需求也日益增加。在所有地區，供應鏈韌性和監管協調仍然是重中之重，尤其對於疫苗和生技藥品，因為它們需要冷鏈完整性和嚴格的品管。區域貿易協定和生產激勵措施影響企業生產和分銷基地的選址，以及它們如何制定打入市場策略，以平衡上市速度、合規性和成本效益。

因此，區域領導者和全球團隊必須緊密合作。成功的策略是將本地市場情報、監管專業知識以及與區域經銷商的夥伴關係相結合，同時利用研發和製造方面的集中化主導來維持產品品質和規模經濟效益。

結合產品創新、夥伴關係和商業性靈活性的競爭策略，可確保動物用藥品在臨床上的應用和永續成長。

動物用藥品領域的競爭地位取決於產品系列、垂直整合和策略夥伴關係關係。領先企業往往將疫苗平台、專有藥物和診斷能力的優勢與覆蓋診所、藥房和線上管道的廣泛分銷和服務相結合。投資於製劑科學和給藥技術的企業在使用者便利性和依從性方面更具優勢，尤其是在慢性病治療和寄生蟲控制方案方面。

與飼料生產商、診斷創新者和受託製造廠商建立合作關係，可以加快含藥飼料添加劑和特殊生技藥品的上市速度。授權和共同開發契約是高效將重組疫苗和先進診斷產品推向市場的常用手段，而策略性收購則可以彌補影像和即時檢測技術的能力缺口。此外，積極實施抗菌藥物管理和透明供應鏈實踐的公司，更容易贏得監管機構、獸醫和終端客戶的信任。

最後，靈活的商業模式，例如針對慢性病管理的訂閱服務、面向診所的綜合診斷和治療服務，以及針對非處方藥的直接面對消費者的電子商務策略，將使市場領導者與快速追隨者區分開來。對真實世界證據生成和獸醫教育計畫的投資將進一步加強臨床應用和長期品牌忠誠度。

一系列務實的策略舉措，重點在於診斷、靈活採購、通路差異化、物種特異性研發以及監管溝通，旨在推動商業成功。

為了克服複雜性並抓住機遇，產業領導者應優先考慮幾項高影響力措施。首先，投資診斷整合和即時數據系統將有助於做出更精準的治療決策，減少不合理使用抗生素，並支持向支付者和終端用戶傳遞價值資訊。這需要對即時檢測、影像技術和分析技術進行協調投資，以便將臨床訊號轉化為可執行的通訊協定。

其次，企業應重新評估其採購和生產佈局，以降低關稅和地緣政治風險。在可行的情況下，關鍵投入品的近岸外包或雙重採購策略，以及建立長期供應商夥伴關係關係，可以在不犧牲成本競爭力的前提下增強抵禦風險的能力。第三，企業應採取差異化的分銷策略，充分利用其線上通路、藥房網路和診所關係的優勢。這意味著要建構針對特定管道的價值主張和服務模式，以反映獨特的客戶體驗歷程。

第四，開發平臺與特定物種的需求和使用偏好相匹配，可以提高產品普及率。優先研發便於飼主農場工作人員使用的配方，並推動穩定性更高的疫苗平台，可降低使用門檻。最後，積極參與監管事務和舉措，可以保護產品完整性，並促進產品更順利地進入市場。這些措施共同構成了將洞見轉化為行動的實際可行的藍圖。

我們以實證為基礎的研究途徑結合了依證訪談、二手檢驗和情境壓力測試，從而得出可操作、可直接用於決策的洞見。

本執行摘要的調查方法結合了多種手段，以確保其可靠性和有效性。主要研究包括：對伴侶動物、馬匹和牲畜獸醫進行結構化訪談；與製藥、疫苗和診斷領域的資深商業領袖進行討論；以及與線上管道、零售藥局和診所管道的分銷合作夥伴進行諮詢。這些訪談提供了關於產品推廣促進因素、給藥偏好和通路經濟效益的第一線觀點。

二次分析利用同行評審文獻、監管指南、行業技術標準和上市公司披露資訊，檢驗了產品創新、生產能力和政策發展趨勢。貿易政策和供應鏈評估納入了公開的關稅公告和政府聲明，以模擬預期的營運應對措施，但並未得出量化的市場估計值。為減少偏差並提高適用性，對不同產品類型、治療領域和地區進行了交叉檢驗。

最後，調查方法強調了實際應用性：透過與商業和監管專家進行情境研討會，對研究結果進行壓力測試，以完善策略建議，並確保提案的行動在現有的組織約束和時間範圍內是可行的。

總結性分析將物種特定優先事項、不斷演變的分銷模式和政策主導的供應鏈應對措施聯繫起來，並為領導者提供了明確的策略啟示。

摘要：獸醫領域正朝著以數位化管道和在地化生產策略為支撐的、以診斷主導的綜合醫療模式發展。從犬貓等伴侶動物到馬、牛、雞、豬等生產動物，不同物種在產品開發、監管溝通和配銷通路設計等方面都需要量身定做的解決方案。產品創新的重點也日益轉向診斷賦能、先進的疫苗平台以及能夠適應實際用藥限制的易用型製劑。

主要市場貿易政策（包括關稅）的轉變迫使企業調整採購和庫存策略，同時與政策制定者合作，以保護重要的動物用藥品。不同區域的市場動態凸顯了市場准入和生產決策的必要性，這些決策必須反映美洲、歐洲、中東和非洲以及亞太地區的法規環境和物流實際情況。對於商業領袖而言，與競爭對手合作、投資於照護現場能力以及積極參與監管事務，是實現永續成長和降低風險的有效途徑。

綜上所述，這些結論為高階主管提供了一個策略視角，以便他們優先考慮投資、協調跨職能團隊，並加快推進各項工作，從而在動物健康結果和組織韌性方面取得可衡量的改進。

目錄

第1章：序言

第2章調查方法

第3章執行摘要

第4章 市場概覽

第5章 市場洞察

  • 整合遠端醫療平台，進行遠距獸醫諮詢，以改善病患治療效果，減少診所擁擠。
  • 寵物癌症發生率的不斷上升，推動了獸醫腫瘤治療領域對生技藥品和生物相似藥的需求。
  • 推出用於持續收集動物健康數據和進行預測分析的智慧穿戴監測設備
  • 將行動獸醫服務擴展到服務不足的農村地區，可以改善人們獲得預防性護理的機會。
  • 人工智慧演算法在寵物影像和疾病檢測的應用日益廣泛
  • 基於動物遺傳學和微生物組分析的個人化營養和膳食補充劑配方發展
  • 促進對具有新型作用機制的新型殺寄生蟲藥物的監管，以對抗抗蠕蟲藥物抗藥性。

第6章：美國關稅的累積影響，2025年

第7章：人工智慧的累積影響，2025年

第8章 依動物類型分類的動物用藥品市場

  • 伴侶動物
    • 貓
    • 狗
  • 馬科部門
    • 馬
  • 家畜
    • 牛
    • 家禽
    • 豬

第9章 依產品類型分類的動物用藥品市場

  • 診斷
    • 影像
    • 感染疾病
  • 藥品和飼料添加劑
  • 製藥
    • 學名藥
    • 非處方藥
    • 處方藥
  • 疫苗
    • 去活化疫苗
    • 活病毒疫苗
    • 重組

第10章 按分銷管道分類的動物用藥品市場

  • 網路商店
  • 藥局
  • 獸醫診所

第11章 依治療領域分類的動物用藥品市場

  • 抗感染藥物
    • 抗生素
    • 抗真菌藥物
    • 抗病毒藥物
  • 抗發炎藥
  • 心血管系統
  • 殺寄生蟲劑
    • 體外寄生蟲殺滅劑
    • Endectocides

第12章 依給藥途徑分類的動物用藥品市場

  • 吸入
  • 注射
  • 口服
  • 外用

第13章 按地區分類的動物用藥品市場

  • 美洲
    • 北美洲
    • 拉丁美洲
  • 歐洲、中東和非洲
    • 歐洲
    • 中東
    • 非洲
  • 亞太地區

第14章動物用藥品市場：依類別分類

  • ASEAN
  • GCC
  • EU
  • BRICS
  • G7
  • NATO

第15章 各國動物用藥品市場

  • 美國
  • 加拿大
  • 墨西哥
  • 巴西
  • 英國
  • 德國
  • 法國
  • 俄羅斯
  • 義大利
  • 西班牙
  • 中國
  • 印度
  • 日本
  • 澳洲
  • 韓國

第16章 競爭格局

  • 2024年市佔率分析
  • FPNV定位矩陣，2024
  • 競爭分析
    • Zoetis Inc.
    • Merck & Co., Inc.
    • Boehringer Ingelheim International GmbH
    • Elanco Animal Health Incorporated
    • IDEXX Laboratories, Inc.
    • Ceva Sante Animale SA
    • Vetoquinol SA
    • Virbac SA
    • Dechra Pharmaceuticals plc
    • Phibro Animal Health Corporation
Product Code: MRR-221461476D1E

The Veterinary Medicine Market is projected to grow by USD 83.91 billion at a CAGR of 7.94% by 2032.

KEY MARKET STATISTICS
Base Year [2024] USD 45.51 billion
Estimated Year [2025] USD 49.10 billion
Forecast Year [2032] USD 83.91 billion
CAGR (%) 7.94%

A concise orientation to the evolving veterinary medicine ecosystem emphasizing integrated care, preventive strategies, and commercial imperatives for decision-makers

The veterinary medicine sector stands at an inflection point where technological innovation, shifting consumption patterns, and evolving regulatory landscapes are reshaping clinical practice, product development, and distribution. This executive summary provides a concise synthesis of the structural drivers, competitive dynamics, and operational implications that senior leaders must consider to navigate near-term disruptions and longer-term strategic opportunities.

Over recent years, veterinary care has moved beyond episodic treatment toward integrated animal health management that emphasizes preventive care, diagnostics-led decision making, and data-driven outcomes. These trends are especially pronounced in companion animal care, where pet owners increasingly prioritize convenience, digital engagement, and higher standards of therapeutic outcomes. At the same time, livestock and equine segments are experiencing heightened scrutiny on biosecurity, productivity, and feed efficiency, prompting shifts in product mix and service delivery.

Consequently, corporate leaders must align R&D priorities, go-to-market models, and supply chain resilience with these multi-vector changes. This introduction frames the subsequent sections, which explore transformative shifts across the ecosystem, tariff-related trade implications projected for 2025, segmentation-level insights, regional dynamics, competitive positioning, actionable recommendations, and the research approach underpinning the findings. The narrative purposefully integrates species, product, distribution, therapeutic, and administration dimensions so that stakeholders can translate strategic implications into practical initiatives.

How diagnostics-led care, digital channels, and supply chain localization are redefining product development and service delivery across veterinary medicine

Fundamental shifts are transforming how veterinary health services are delivered, how products are developed, and how commercial value is captured. One major change is the convergence of diagnostics and therapeutics: faster, point-of-care diagnostics and advanced imaging are enabling earlier intervention, which in turn drives demand for targeted pharmaceuticals and vaccines. This diagnostic-enabled model is reshaping clinical protocols for companion animals such as cats and dogs, while also informing herd health strategies for cattle, poultry, and swine.

Another transformative movement is the rapid adoption of digital and remote care models. Telemedicine and digital triage platforms have become a viable complement to traditional clinic visits, particularly in urban companion animal markets and in regions where clinic density is low. These digital capabilities are altering the distribution landscape, creating opportunities for online stores to partner with pharmacies and veterinary clinics to provide integrated care journeys. They also permit more efficient chronic disease management across therapeutic areas such as anti-infectives and anti-inflammatories.

Supply chain localization and manufacturing innovation constitute a third major shift. In response to geopolitical uncertainty and pandemic lessons, firms are accelerating investments in localized formulation and fill-finish capacity, as well as in alternative routes of administration such as injectables, oral formulations, and topical therapies that align with field conditions. Finally, there is a rising emphasis on formulation science and novel vaccine platforms that address species-specific needs-ranging from recombinant vaccines for equine applications to improved inactivated vaccine stability for livestock-thereby changing product development roadmaps and regulatory engagement strategies.

Assessing the strategic consequences of United States tariff measures in 2025 for supply chains, sourcing choices, and pricing dynamics across veterinary product categories

Trade policy changes and tariff actions can materially influence input costs, supply chain strategies, and pricing dynamics across the veterinary medicines value chain. In the context of tariffs enacted or proposed in the United States in 2025, manufacturers and distributors are facing renewed pressure to reassess sourcing strategies for active pharmaceutical ingredients, vaccine components, and diagnostic equipment. These tariff measures tend to increase landed costs for imported raw materials and finished goods, which encourages firms to evaluate options including supplier diversification, nearshoring, and long-term purchasing agreements.

As companies respond, logistics and inventory strategies will also adapt. Firms may increase safety stock levels or shift to multi-sourcing to mitigate exposure, while contract manufacturers and distributors reassess contractual terms to allocate risk more explicitly. In parallel, pricing discipline becomes critical: firms must consider how to balance cost recovery with competitive positioning, especially in price-sensitive channels such as online stores and pharmacies. For therapeutic categories where alternatives exist-such as generic pharmaceuticals versus brand prescription drugs-tariff-induced cost differentials can accelerate substitution or, conversely, reinforce demand for domestically produced branded solutions.

Regulatory and policy responses will further shape outcomes. Policymakers may implement targeted exemptions for essential veterinary products to preserve animal health and food security, or they may incentivize domestic production through tax credits and grants. Therefore, senior leaders should monitor trade policy developments closely while engaging with industry associations and regulatory bodies to advocate for predictable trade frameworks that protect both animal health and sectoral resilience.

Segment-level strategic guidance that aligns species-specific needs, product modalities, therapeutic priorities, distribution channels, and routes of administration for better decision-making

A nuanced segmentation view is indispensable for translating market dynamics into actionable commercial plans. Based on animal type, stakeholders must differentiate strategies across companion animal segments-where cats and dogs dominate clinical demand and consumer spending-from equine markets, which have unique performance and wellness needs centered on horses, and livestock sectors comprising cattle, poultry, and swine where scale, biosecurity, and feed efficiency drive product adoption. Each animal category presents distinct purchasing patterns, regulatory touchpoints, and channel preferences.

Product type segmentation reveals divergent innovation and commercialization pathways. Diagnostics encompass imaging modalities and infectious disease assays that are increasingly deployed at point of care, influencing downstream pharmaceutical and vaccine utilization. Medicated feed additives target production efficiency in livestock, requiring close alignment with feed manufacturers and farm management systems. Pharmaceuticals span generic drugs, over-the-counter remedies, and prescription medicines, each with different regulatory burdens and margin profiles. Vaccines include inactivated, live attenuated, and recombinant platforms, and they demand specialized cold-chain and administration capabilities.

Distribution channel segmentation-consisting of online stores, pharmacies, and veterinary clinics-determines customer access models and margin structures. Online channels excel in convenience and subscription models, pharmacies provide retail reach for OTC products, and clinics combine diagnosis with point-of-care treatment. Therapeutic area distinctions across anti-infectives, anti-inflammatories, cardiovascular agents, and parasiticides inform R&D prioritization; within anti-infectives, antibiotics, antifungals, and antivirals each require targeted stewardship strategies, while parasiticides separate into ectoparasiticides and endectocides with differing administration regimens. Route of administration considerations-covering inhalation, injectable, oral, and topical formats-further influence product design, user training needs, and adoption curves.

Regional dynamics and cross-border considerations that influence regulatory alignment, manufacturing decisions, and distribution strategies across major global regions

Regional dynamics materially shape regulatory regimes, distribution architectures, and investment priorities across veterinary medicine. In the Americas, markets often feature mature companion animal care ecosystems, a strong retail pharmacy presence, and expanding digital health adoption; these characteristics support higher per-animal spend in urban centers and create attractive channels for diagnostics and prescription pharmaceuticals. In contrast, the Europe, Middle East & Africa region displays heterogeneity, with advanced regulatory frameworks and high veterinary standards in many European markets, while certain Middle East and African jurisdictions prioritize livestock health and biosecurity to safeguard food supply chains.

Asia-Pacific is marked by rapid modernization of veterinary services, with growing investment in manufacturing capacity and rising demand for both companion and production animal products. Across all regions, supply chain resilience and regulatory harmonization remain salient priorities, especially for vaccines and biologics that require cold-chain integrity and stringent quality controls. Regional trade agreements and local manufacturing incentives influence where companies choose to site production and distribution hubs, and they affect how firms design market entry strategies that balance speed to market with compliance and cost efficiency.

Consequently, regional leaders and global teams must coordinate closely; successful approaches integrate local market intelligence, regulatory affairs expertise, and partnerships with regional distributors, while also leveraging center-led capabilities in R&D and manufacturing to maintain quality and scale economies.

Competitive strategies that combine product innovation, partnerships, and commercial agility to secure clinical adoption and sustainable growth in veterinary medicine

Competitive positioning in veterinary medicine is shaped by product portfolios, vertical integration, and strategic partnerships. Leading firms tend to combine strengths in vaccine platforms, proprietary pharmaceuticals, and diagnostic capabilities with broad distribution networks and service offerings that span clinics, pharmacies, and online channels. Companies investing in formulation science and delivery technologies secure advantages in user convenience and adherence, particularly for chronic therapeutic areas and parasiticide regimens.

Collaboration remains a key tactic: alliances with feed producers, diagnostic innovators, and contract manufacturing organizations accelerate route-to-market for medicated feed additives and specialty biologics. Licensing and co-development agreements are common for bringing recombinant vaccines and advanced diagnostics to market efficiently, while strategic acquisitions can fill capability gaps in imaging or point-of-care assay technologies. Additionally, firms that proactively engage in antimicrobial stewardship and transparent supply chain practices earn greater trust among regulators, veterinarians, and end customers.

Finally, agility in commercial models-such as subscription services for chronic disease management, bundled diagnostics-therapy offerings for clinics, and direct-to-consumer e-commerce strategies for OTC products-differentiates market leaders from fast followers. Investment in real-world evidence generation and veterinarian education programs further strengthens clinical adoption and long-term brand loyalty.

A pragmatic set of strategic moves focused on diagnostics, resilient sourcing, channel differentiation, species-aligned R&D, and regulatory engagement to drive commercialization success

Industry leaders should prioritize a few high-impact initiatives to navigate complexity and capture opportunities. First, investing in diagnostic integration and real-time data systems will enable more precise therapeutic decisions, reduce inappropriate antimicrobial use, and support value communication to payers and end users. This requires coordinated investments in point-of-care testing, imaging capabilities, and analytics that translate clinical signals into actionable protocols.

Second, companies should reassess sourcing and manufacturing footprints to mitigate tariff and geopolitical risks. Where feasible, nearshoring or dual-sourcing strategies for critical inputs, along with long-term supplier partnerships, will enhance resilience without sacrificing cost competitiveness. Third, firms need to adopt differentiated distribution strategies that exploit the strengths of online channels, pharmacy networks, and clinic relationships; this means creating channel-specific value propositions and service models that reflect distinct customer journeys.

Fourth, aligning R&D pipelines with species-specific needs and administration preferences will improve adoption rates. Prioritizing formulations that simplify administration for owners and farm staff, and advancing vaccine platforms with improved stability, will lower barriers to use. Lastly, proactive regulatory engagement and participation in stewardship initiatives will protect product credibility and enable smoother market access. Together, these actions form a pragmatic roadmap for translating insight into execution.

An evidence-based research approach combining qualitative interviews, secondary validation, and scenario stress-testing to derive practical, decision-ready insights

The research underpinning this executive summary combines multiple methodological approaches to ensure reliability and relevance. Primary qualitative research included structured interviews with veterinarians across companion, equine, and livestock practices, discussions with senior commercial leaders in pharmaceuticals, vaccines, and diagnostics, and consultations with distribution partners operating online, retail pharmacy, and clinic channels. These interviews provided frontline perspectives on adoption drivers, administration preferences, and channel economics.

Secondary analysis drew on peer-reviewed literature, regulatory guidance, industry technical standards, and public company disclosures to validate trends in product innovation, manufacturing capacity, and policy developments. Trade policy and supply chain assessments incorporated publicly available tariff announcements and government statements to model likely operational responses without producing quantitative market estimates. Cross-validation exercises were used to triangulate insights across species, product types, therapeutic areas, and regions to reduce bias and enhance applicability.

Finally, the methodology emphasized practical applicability: findings were stress-tested through scenario workshops with commercial and regulatory experts to refine strategic recommendations and to ensure that suggested actions are feasible within typical organizational constraints and timelines.

Concluding synthesis that links species-specific priorities, evolving distribution models, and policy-driven supply chain responses into clear strategic implications for leaders

In summary, the veterinary medicine landscape is evolving toward integrated, diagnostic-led care supported by digital channels and localized manufacturing strategies. Species differences-from companion animals such as cats and dogs to horses and to production animals like cattle, poultry, and swine-require tailored approaches across product development, regulatory engagement, and distribution design. Product innovation is increasingly centered on diagnostic enablement, advanced vaccine platforms, and user-friendly formulations that match real-world administration constraints.

Trade policy shifts, including tariff actions in major markets, are prompting companies to reconfigure sourcing and inventory strategies while engaging with policymakers to safeguard essential animal health products. Regionally differentiated market dynamics underscore the need for market entry and manufacturing decisions that reflect local regulatory environments and logistical realities across the Americas, Europe, Middle East & Africa, and Asia-Pacific. For commercial leaders, the combination of competitive collaboration, investment in point-of-care capabilities, and disciplined regulatory engagement presents a coherent path to sustain growth and mitigate risk.

Taken together, these conclusions provide a strategic lens for executives to prioritize investments, align cross-functional teams, and accelerate initiatives that deliver measurable improvements in animal health outcomes and organizational resilience.

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Integration of telemedicine platforms for remote veterinary consultations improving patient outcomes and reducing clinic congestion
  • 5.2. Rising demand for biologics and biosimilars in veterinary oncology treatments driven by growing pet cancer incidence
  • 5.3. Adoption of smart wearable monitoring devices for continuous animal health data collection and predictive analytics
  • 5.4. Expansion of mobile veterinary services to underserved rural areas enabling improved access to preventive care
  • 5.5. Increasing use of artificial intelligence algorithms for diagnostic imaging and disease detection in pets
  • 5.6. Growth of personalized nutrition and nutraceutical formulations based on genetics and microbiome profiling of animals
  • 5.7. Regulatory acceleration of novel parasiticides leveraging novel modes of action to combat anthelmintic resistance

6. Cumulative Impact of United States Tariffs 2025

7. Cumulative Impact of Artificial Intelligence 2025

8. Veterinary Medicine Market, by Animal Type

  • 8.1. Companion Animal
    • 8.1.1. Cat
    • 8.1.2. Dog
  • 8.2. Equine
    • 8.2.1. Horse
  • 8.3. Livestock
    • 8.3.1. Cattle
    • 8.3.2. Poultry
    • 8.3.3. Swine

9. Veterinary Medicine Market, by Product Type

  • 9.1. Diagnostics
    • 9.1.1. Imaging
    • 9.1.2. Infectious Disease
  • 9.2. Medicated Feed Additives
  • 9.3. Pharmaceuticals
    • 9.3.1. Generic Drugs
    • 9.3.2. Over The Counter Drugs
    • 9.3.3. Prescription Drugs
  • 9.4. Vaccines
    • 9.4.1. Inactivated
    • 9.4.2. Live Attenuated
    • 9.4.3. Recombinant

10. Veterinary Medicine Market, by Distribution Channel

  • 10.1. Online Stores
  • 10.2. Pharmacies
  • 10.3. Veterinary Clinics

11. Veterinary Medicine Market, by Therapeutic Area

  • 11.1. Anti Infectives
    • 11.1.1. Antibiotics
    • 11.1.2. Antifungals
    • 11.1.3. Antivirals
  • 11.2. Anti Inflammatories
  • 11.3. Cardiovascular
  • 11.4. Parasiticides
    • 11.4.1. Ectoparasiticides
    • 11.4.2. Endectocides

12. Veterinary Medicine Market, by Route Of Administration

  • 12.1. Inhalation
  • 12.2. Injectable
  • 12.3. Oral
  • 12.4. Topical

13. Veterinary Medicine Market, by Region

  • 13.1. Americas
    • 13.1.1. North America
    • 13.1.2. Latin America
  • 13.2. Europe, Middle East & Africa
    • 13.2.1. Europe
    • 13.2.2. Middle East
    • 13.2.3. Africa
  • 13.3. Asia-Pacific

14. Veterinary Medicine Market, by Group

  • 14.1. ASEAN
  • 14.2. GCC
  • 14.3. European Union
  • 14.4. BRICS
  • 14.5. G7
  • 14.6. NATO

15. Veterinary Medicine Market, by Country

  • 15.1. United States
  • 15.2. Canada
  • 15.3. Mexico
  • 15.4. Brazil
  • 15.5. United Kingdom
  • 15.6. Germany
  • 15.7. France
  • 15.8. Russia
  • 15.9. Italy
  • 15.10. Spain
  • 15.11. China
  • 15.12. India
  • 15.13. Japan
  • 15.14. Australia
  • 15.15. South Korea

16. Competitive Landscape

  • 16.1. Market Share Analysis, 2024
  • 16.2. FPNV Positioning Matrix, 2024
  • 16.3. Competitive Analysis
    • 16.3.1. Zoetis Inc.
    • 16.3.2. Merck & Co., Inc.
    • 16.3.3. Boehringer Ingelheim International GmbH
    • 16.3.4. Elanco Animal Health Incorporated
    • 16.3.5. IDEXX Laboratories, Inc.
    • 16.3.6. Ceva Sante Animale S.A.
    • 16.3.7. Vetoquinol S.A.
    • 16.3.8. Virbac S.A.
    • 16.3.9. Dechra Pharmaceuticals plc
    • 16.3.10. Phibro Animal Health Corporation

LIST OF FIGURES

  • FIGURE 1. GLOBAL VETERINARY MEDICINE MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 2. GLOBAL VETERINARY MEDICINE MARKET SIZE, BY ANIMAL TYPE, 2024 VS 2032 (%)
  • FIGURE 3. GLOBAL VETERINARY MEDICINE MARKET SIZE, BY ANIMAL TYPE, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 4. GLOBAL VETERINARY MEDICINE MARKET SIZE, BY PRODUCT TYPE, 2024 VS 2032 (%)
  • FIGURE 5. GLOBAL VETERINARY MEDICINE MARKET SIZE, BY PRODUCT TYPE, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 6. GLOBAL VETERINARY MEDICINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024 VS 2032 (%)
  • FIGURE 7. GLOBAL VETERINARY MEDICINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 8. GLOBAL VETERINARY MEDICINE MARKET SIZE, BY THERAPEUTIC AREA, 2024 VS 2032 (%)
  • FIGURE 9. GLOBAL VETERINARY MEDICINE MARKET SIZE, BY THERAPEUTIC AREA, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 10. GLOBAL VETERINARY MEDICINE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2024 VS 2032 (%)
  • FIGURE 11. GLOBAL VETERINARY MEDICINE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 12. GLOBAL VETERINARY MEDICINE MARKET SIZE, BY REGION, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 13. AMERICAS VETERINARY MEDICINE MARKET SIZE, BY SUBREGION, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 14. NORTH AMERICA VETERINARY MEDICINE MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 15. LATIN AMERICA VETERINARY MEDICINE MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 16. EUROPE, MIDDLE EAST & AFRICA VETERINARY MEDICINE MARKET SIZE, BY SUBREGION, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 17. EUROPE VETERINARY MEDICINE MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 18. MIDDLE EAST VETERINARY MEDICINE MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 19. AFRICA VETERINARY MEDICINE MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 20. ASIA-PACIFIC VETERINARY MEDICINE MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 21. GLOBAL VETERINARY MEDICINE MARKET SIZE, BY GROUP, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 22. ASEAN VETERINARY MEDICINE MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 23. GCC VETERINARY MEDICINE MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 24. EUROPEAN UNION VETERINARY MEDICINE MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 25. BRICS VETERINARY MEDICINE MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 26. G7 VETERINARY MEDICINE MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 27. NATO VETERINARY MEDICINE MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 28. GLOBAL VETERINARY MEDICINE MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 29. VETERINARY MEDICINE MARKET SHARE, BY KEY PLAYER, 2024
  • FIGURE 30. VETERINARY MEDICINE MARKET, FPNV POSITIONING MATRIX, 2024

LIST OF TABLES

  • TABLE 1. VETERINARY MEDICINE MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
  • TABLE 3. GLOBAL VETERINARY MEDICINE MARKET SIZE, 2018-2024 (USD MILLION)
  • TABLE 4. GLOBAL VETERINARY MEDICINE MARKET SIZE, 2025-2032 (USD MILLION)
  • TABLE 5. GLOBAL VETERINARY MEDICINE MARKET SIZE, BY ANIMAL TYPE, 2018-2024 (USD MILLION)
  • TABLE 6. GLOBAL VETERINARY MEDICINE MARKET SIZE, BY ANIMAL TYPE, 2025-2032 (USD MILLION)
  • TABLE 7. GLOBAL VETERINARY MEDICINE MARKET SIZE, BY COMPANION ANIMAL, 2018-2024 (USD MILLION)
  • TABLE 8. GLOBAL VETERINARY MEDICINE MARKET SIZE, BY COMPANION ANIMAL, 2025-2032 (USD MILLION)
  • TABLE 9. GLOBAL VETERINARY MEDICINE MARKET SIZE, BY COMPANION ANIMAL, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 10. GLOBAL VETERINARY MEDICINE MARKET SIZE, BY COMPANION ANIMAL, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 11. GLOBAL VETERINARY MEDICINE MARKET SIZE, BY COMPANION ANIMAL, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 12. GLOBAL VETERINARY MEDICINE MARKET SIZE, BY COMPANION ANIMAL, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 13. GLOBAL VETERINARY MEDICINE MARKET SIZE, BY COMPANION ANIMAL, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 14. GLOBAL VETERINARY MEDICINE MARKET SIZE, BY COMPANION ANIMAL, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 15. GLOBAL VETERINARY MEDICINE MARKET SIZE, BY CAT, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 16. GLOBAL VETERINARY MEDICINE MARKET SIZE, BY CAT, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 17. GLOBAL VETERINARY MEDICINE MARKET SIZE, BY CAT, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 18. GLOBAL VETERINARY MEDICINE MARKET SIZE, BY CAT, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 19. GLOBAL VETERINARY MEDICINE MARKET SIZE, BY CAT, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 20. GLOBAL VETERINARY MEDICINE MARKET SIZE, BY CAT, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 21. GLOBAL VETERINARY MEDICINE MARKET SIZE, BY DOG, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 22. GLOBAL VETERINARY MEDICINE MARKET SIZE, BY DOG, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 23. GLOBAL VETERINARY MEDICINE MARKET SIZE, BY DOG, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 24. GLOBAL VETERINARY MEDICINE MARKET SIZE, BY DOG, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 25. GLOBAL VETERINARY MEDICINE MARKET SIZE, BY DOG, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 26. GLOBAL VETERINARY MEDICINE MARKET SIZE, BY DOG, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 27. GLOBAL VETERINARY MEDICINE MARKET SIZE, BY EQUINE, 2018-2024 (USD MILLION)
  • TABLE 28. GLOBAL VETERINARY MEDICINE MARKET SIZE, BY EQUINE, 2025-2032 (USD MILLION)
  • TABLE 29. GLOBAL VETERINARY MEDICINE MARKET SIZE, BY EQUINE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 30. GLOBAL VETERINARY MEDICINE MARKET SIZE, BY EQUINE, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 31. GLOBAL VETERINARY MEDICINE MARKET SIZE, BY EQUINE, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 32. GLOBAL VETERINARY MEDICINE MARKET SIZE, BY EQUINE, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 33. GLOBAL VETERINARY MEDICINE MARKET SIZE, BY EQUINE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 34. GLOBAL VETERINARY MEDICINE MARKET SIZE, BY EQUINE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 35. GLOBAL VETERINARY MEDICINE MARKET SIZE, BY HORSE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 36. GLOBAL VETERINARY MEDICINE MARKET SIZE, BY HORSE, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 37. GLOBAL VETERINARY MEDICINE MARKET SIZE, BY HORSE, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 38. GLOBAL VETERINARY MEDICINE MARKET SIZE, BY HORSE, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 39. GLOBAL VETERINARY MEDICINE MARKET SIZE, BY HORSE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 40. GLOBAL VETERINARY MEDICINE MARKET SIZE, BY HORSE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 41. GLOBAL VETERINARY MEDICINE MARKET SIZE, BY LIVESTOCK, 2018-2024 (USD MILLION)
  • TABLE 42. GLOBAL VETERINARY MEDICINE MARKET SIZE, BY LIVESTOCK, 2025-2032 (USD MILLION)
  • TABLE 43. GLOBAL VETERINARY MEDICINE MARKET SIZE, BY LIVESTOCK, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 44. GLOBAL VETERINARY MEDICINE MARKET SIZE, BY LIVESTOCK, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 45. GLOBAL VETERINARY MEDICINE MARKET SIZE, BY LIVESTOCK, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 46. GLOBAL VETERINARY MEDICINE MARKET SIZE, BY LIVESTOCK, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 47. GLOBAL VETERINARY MEDICINE MARKET SIZE, BY LIVESTOCK, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 48. GLOBAL VETERINARY MEDICINE MARKET SIZE, BY LIVESTOCK, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 49. GLOBAL VETERINARY MEDICINE MARKET SIZE, BY CATTLE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 50. GLOBAL VETERINARY MEDICINE MARKET SIZE, BY CATTLE, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 51. GLOBAL VETERINARY MEDICINE MARKET SIZE, BY CATTLE, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 52. GLOBAL VETERINARY MEDICINE MARKET SIZE, BY CATTLE, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 53. GLOBAL VETERINARY MEDICINE MARKET SIZE, BY CATTLE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 54. GLOBAL VETERINARY MEDICINE MARKET SIZE, BY CATTLE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 55. GLOBAL VETERINARY MEDICINE MARKET SIZE, BY POULTRY, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 56. GLOBAL VETERINARY MEDICINE MARKET SIZE, BY POULTRY, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 57. GLOBAL VETERINARY MEDICINE MARKET SIZE, BY POULTRY, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 58. GLOBAL VETERINARY MEDICINE MARKET SIZE, BY POULTRY, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 59. GLOBAL VETERINARY MEDICINE MARKET SIZE, BY POULTRY, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 60. GLOBAL VETERINARY MEDICINE MARKET SIZE, BY POULTRY, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 61. GLOBAL VETERINARY MEDICINE MARKET SIZE, BY SWINE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 62. GLOBAL VETERINARY MEDICINE MARKET SIZE, BY SWINE, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 63. GLOBAL VETERINARY MEDICINE MARKET SIZE, BY SWINE, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 64. GLOBAL VETERINARY MEDICINE MARKET SIZE, BY SWINE, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 65. GLOBAL VETERINARY MEDICINE MARKET SIZE, BY SWINE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 66. GLOBAL VETERINARY MEDICINE MARKET SIZE, BY SWINE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 67. GLOBAL VETERINARY MEDICINE MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 68. GLOBAL VETERINARY MEDICINE MARKET SIZE, BY PRODUCT TYPE, 2025-2032 (USD MILLION)
  • TABLE 69. GLOBAL VETERINARY MEDICINE MARKET SIZE, BY DIAGNOSTICS, 2018-2024 (USD MILLION)
  • TABLE 70. GLOBAL VETERINARY MEDICINE MARKET SIZE, BY DIAGNOSTICS, 2025-2032 (USD MILLION)
  • TABLE 71. GLOBAL VETERINARY MEDICINE MARKET SIZE, BY DIAGNOSTICS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 72. GLOBAL VETERINARY MEDICINE MARKET SIZE, BY DIAGNOSTICS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 73. GLOBAL VETERINARY MEDICINE MARKET SIZE, BY DIAGNOSTICS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 74. GLOBAL VETERINARY MEDICINE MARKET SIZE, BY DIAGNOSTICS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 75. GLOBAL VETERINARY MEDICINE MARKET SIZE, BY DIAGNOSTICS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 76. GLOBAL VETERINARY MEDICINE MARKET SIZE, BY DIAGNOSTICS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 77. GLOBAL VETERINARY MEDICINE MARKET SIZE, BY IMAGING, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 78. GLOBAL VETERINARY MEDICINE MARKET SIZE, BY IMAGING, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 79. GLOBAL VETERINARY MEDICINE MARKET SIZE, BY IMAGING, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 80. GLOBAL VETERINARY MEDICINE MARKET SIZE, BY IMAGING, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 81. GLOBAL VETERINARY MEDICINE MARKET SIZE, BY IMAGING, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 82. GLOBAL VETERINARY MEDICINE MARKET SIZE, BY IMAGING, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 83. GLOBAL VETERINARY MEDICINE MARKET SIZE, BY INFECTIOUS DISEASE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 84. GLOBAL VETERINARY MEDICINE MARKET SIZE, BY INFECTIOUS DISEASE, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 85. GLOBAL VETERINARY MEDICINE MARKET SIZE, BY INFECTIOUS DISEASE, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 86. GLOBAL VETERINARY MEDICINE MARKET SIZE, BY INFECTIOUS DISEASE, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 87. GLOBAL VETERINARY MEDICINE MARKET SIZE, BY INFECTIOUS DISEASE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 88. GLOBAL VETERINARY MEDICINE MARKET SIZE, BY INFECTIOUS DISEASE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 89. GLOBAL VETERINARY MEDICINE MARKET SIZE, BY MEDICATED FEED ADDITIVES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 90. GLOBAL VETERINARY MEDICINE MARKET SIZE, BY MEDICATED FEED ADDITIVES, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 91. GLOBAL VETERINARY MEDICINE MARKET SIZE, BY MEDICATED FEED ADDITIVES, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 92. GLOBAL VETERINARY MEDICINE MARKET SIZE, BY MEDICATED FEED ADDITIVES, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 93. GLOBAL VETERINARY MEDICINE MARKET SIZE, BY MEDICATED FEED ADDITIVES, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 94. GLOBAL VETERINARY MEDICINE MARKET SIZE, BY MEDICATED FEED ADDITIVES, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 95. GLOBAL VETERINARY MEDICINE MARKET SIZE, BY PHARMACEUTICALS, 2018-2024 (USD MILLION)
  • TABLE 96. GLOBAL VETERINARY MEDICINE MARKET SIZE, BY PHARMACEUTICALS, 2025-2032 (USD MILLION)
  • TABLE 97. GLOBAL VETERINARY MEDICINE MARKET SIZE, BY PHARMACEUTICALS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 98. GLOBAL VETERINARY MEDICINE MARKET SIZE, BY PHARMACEUTICALS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 99. GLOBAL VETERINARY MEDICINE MARKET SIZE, BY PHARMACEUTICALS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 100. GLOBAL VETERINARY MEDICINE MARKET SIZE, BY PHARMACEUTICALS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 101. GLOBAL VETERINARY MEDICINE MARKET SIZE, BY PHARMACEUTICALS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 102. GLOBAL VETERINARY MEDICINE MARKET SIZE, BY PHARMACEUTICALS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 103. GLOBAL VETERINARY MEDICINE MARKET SIZE, BY GENERIC DRUGS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 104. GLOBAL VETERINARY MEDICINE MARKET SIZE, BY GENERIC DRUGS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 105. GLOBAL VETERINARY MEDICINE MARKET SIZE, BY GENERIC DRUGS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 106. GLOBAL VETERINARY MEDICINE MARKET SIZE, BY GENERIC DRUGS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 107. GLOBAL VETERINARY MEDICINE MARKET SIZE, BY GENERIC DRUGS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 108. GLOBAL VETERINARY MEDICINE MARKET SIZE, BY GENERIC DRUGS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 109. GLOBAL VETERINARY MEDICINE MARKET SIZE, BY OVER THE COUNTER DRUGS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 110. GLOBAL VETERINARY MEDICINE MARKET SIZE, BY OVER THE COUNTER DRUGS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 111. GLOBAL VETERINARY MEDICINE MARKET SIZE, BY OVER THE COUNTER DRUGS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 112. GLOBAL VETERINARY MEDICINE MARKET SIZE, BY OVER THE COUNTER DRUGS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 113. GLOBAL VETERINARY MEDICINE MARKET SIZE, BY OVER THE COUNTER DRUGS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 114. GLOBAL VETERINARY MEDICINE MARKET SIZE, BY OVER THE COUNTER DRUGS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 115. GLOBAL VETERINARY MEDICINE MARKET SIZE, BY PRESCRIPTION DRUGS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 116. GLOBAL VETERINARY MEDICINE MARKET SIZE, BY PRESCRIPTION DRUGS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 117. GLOBAL VETERINARY MEDICINE MARKET SIZE, BY PRESCRIPTION DRUGS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 118. GLOBAL VETERINARY MEDICINE MARKET SIZE, BY PRESCRIPTION DRUGS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 119. GLOBAL VETERINARY MEDICINE MARKET SIZE, BY PRESCRIPTION DRUGS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 120. GLOBAL VETERINARY MEDICINE MARKET SIZE, BY PRESCRIPTION DRUGS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 121. GLOBAL VETERINARY MEDICINE MARKET SIZE, BY VACCINES, 2018-2024 (USD MILLION)
  • TABLE 122. GLOBAL VETERINARY MEDICINE MARKET SIZE, BY VACCINES, 2025-2032 (USD MILLION)
  • TABLE 123. GLOBAL VETERINARY MEDICINE MARKET SIZE, BY VACCINES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 124. GLOBAL VETERINARY MEDICINE MARKET SIZE, BY VACCINES, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 125. GLOBAL VETERINARY MEDICINE MARKET SIZE, BY VACCINES, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 126. GLOBAL VETERINARY MEDICINE MARKET SIZE, BY VACCINES, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 127. GLOBAL VETERINARY MEDICINE MARKET SIZE, BY VACCINES, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 128. GLOBAL VETERINARY MEDICINE MARKET SIZE, BY VACCINES, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 129. GLOBAL VETERINARY MEDICINE MARKET SIZE, BY INACTIVATED, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 130. GLOBAL VETERINARY MEDICINE MARKET SIZE, BY INACTIVATED, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 131. GLOBAL VETERINARY MEDICINE MARKET SIZE, BY INACTIVATED, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 132. GLOBAL VETERINARY MEDICINE MARKET SIZE, BY INACTIVATED, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 133. GLOBAL VETERINARY MEDICINE MARKET SIZE, BY INACTIVATED, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 134. GLOBAL VETERINARY MEDICINE MARKET SIZE, BY INACTIVATED, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 135. GLOBAL VETERINARY MEDICINE MARKET SIZE, BY LIVE ATTENUATED, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 136. GLOBAL VETERINARY MEDICINE MARKET SIZE, BY LIVE ATTENUATED, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 137. GLOBAL VETERINARY MEDICINE MARKET SIZE, BY LIVE ATTENUATED, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 138. GLOBAL VETERINARY MEDICINE MARKET SIZE, BY LIVE ATTENUATED, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 139. GLOBAL VETERINARY MEDICINE MARKET SIZE, BY LIVE ATTENUATED, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 140. GLOBAL VETERINARY MEDICINE MARKET SIZE, BY LIVE ATTENUATED, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 141. GLOBAL VETERINARY MEDICINE MARKET SIZE, BY RECOMBINANT, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 142. GLOBAL VETERINARY MEDICINE MARKET SIZE, BY RECOMBINANT, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 143. GLOBAL VETERINARY MEDICINE MARKET SIZE, BY RECOMBINANT, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 144. GLOBAL VETERINARY MEDICINE MARKET SIZE, BY RECOMBINANT, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 145. GLOBAL VETERINARY MEDICINE MARKET SIZE, BY RECOMBINANT, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 146. GLOBAL VETERINARY MEDICINE MARKET SIZE, BY RECOMBINANT, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 147. GLOBAL VETERINARY MEDICINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
  • TABLE 148. GLOBAL VETERINARY MEDICINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2032 (USD MILLION)
  • TABLE 149. GLOBAL VETERINARY MEDICINE MARKET SIZE, BY ONLINE STORES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 150. GLOBAL VETERINARY MEDICINE MARKET SIZE, BY ONLINE STORES, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 151. GLOBAL VETERINARY MEDICINE MARKET SIZE, BY ONLINE STORES, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 152. GLOBAL VETERINARY MEDICINE MARKET SIZE, BY ONLINE STORES, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 153. GLOBAL VETERINARY MEDICINE MARKET SIZE, BY ONLINE STORES, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 154. GLOBAL VETERINARY MEDICINE MARKET SIZE, BY ONLINE STORES, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 155. GLOBAL VETERINARY MEDICINE MARKET SIZE, BY PHARMACIES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 156. GLOBAL VETERINARY MEDICINE MARKET SIZE, BY PHARMACIES, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 157. GLOBAL VETERINARY MEDICINE MARKET SIZE, BY PHARMACIES, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 158. GLOBAL VETERINARY MEDICINE MARKET SIZE, BY PHARMACIES, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 159. GLOBAL VETERINARY MEDICINE MARKET SIZE, BY PHARMACIES, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 160. GLOBAL VETERINARY MEDICINE MARKET SIZE, BY PHARMACIES, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 161. GLOBAL VETERINARY MEDICINE MARKET SIZE, BY VETERINARY CLINICS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 162. GLOBAL VETERINARY MEDICINE MARKET SIZE, BY VETERINARY CLINICS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 163. GLOBAL VETERINARY MEDICINE MARKET SIZE, BY VETERINARY CLINICS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 164. GLOBAL VETERINARY MEDICINE MARKET SIZE, BY VETERINARY CLINICS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 165. GLOBAL VETERINARY MEDICINE MARKET SIZE, BY VETERINARY CLINICS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 166. GLOBAL VETERINARY MEDICINE MARKET SIZE, BY VETERINARY CLINICS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 167. GLOBAL VETERINARY MEDICINE MARKET SIZE, BY THERAPEUTIC AREA, 2018-2024 (USD MILLION)
  • TABLE 168. GLOBAL VETERINARY MEDICINE MARKET SIZE, BY THERAPEUTIC AREA, 2025-2032 (USD MILLION)
  • TABLE 169. GLOBAL VETERINARY MEDICINE MARKET SIZE, BY ANTI INFECTIVES, 2018-2024 (USD MILLION)
  • TABLE 170. GLOBAL VETERINARY MEDICINE MARKET SIZE, BY ANTI INFECTIVES, 2025-2032 (USD MILLION)
  • TABLE 171. GLOBAL VETERINARY MEDICINE MARKET SIZE, BY ANTI INFECTIVES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 172. GLOBAL VETERINARY MEDICINE MARKET SIZE, BY ANTI INFECTIVES, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 173. GLOBAL VETERINARY MEDICINE MARKET SIZE, BY ANTI INFECTIVES, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 174. GLOBAL VETERINARY MEDICINE MARKET SIZE, BY ANTI INFECTIVES, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 175. GLOBAL VETERINARY MEDICINE MARKET SIZE, BY ANTI INFECTIVES, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 176. GLOBAL VETERINARY MEDICINE MARKET SIZE, BY ANTI INFECTIVES, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 177. GLOBAL VETERINARY MEDICINE MARKET SIZE, BY ANTIBIOTICS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 178. GLOBAL VETERINARY MEDICINE MARKET SIZE, BY ANTIBIOTICS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 179. GLOBAL VETERINARY MEDICINE MARKET SIZE, BY ANTIBIOTICS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 180. GLOBAL VETERINARY MEDICINE MARKET SIZE, BY ANTIBIOTICS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 181. GLOBAL VETERINARY MEDICINE MARKET SIZE, BY ANTIBIOTICS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 182. GLOBAL VETERINARY MEDICINE MARKET SIZE, BY ANTIBIOTICS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 183. GLOBAL VETERINARY MEDICINE MARKET SIZE, BY ANTIFUNGALS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 184. GLOBAL VETERINARY MEDICINE MARKET SIZE, BY ANTIFUNGALS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 185. GLOBAL VETERINARY MEDICINE MARKET SIZE, BY ANTIFUNGALS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 186. GLOBAL VETERINARY MEDICINE MARKET SIZE, BY ANTIFUNGALS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 187. GLOBAL VETERINARY MEDICINE MARKET SIZE, BY ANTIFUNGALS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 188. GLOBAL VETERINARY MEDICINE MARKET SIZE, BY ANTIFUNGALS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 189. GLOBAL VETERINARY MEDICINE MARKET SIZE, BY ANTIVIRALS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 190. GLOBAL VETERINARY MEDICINE MARKET SIZE, BY ANTIVIRALS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 191. GLOBAL VETERINARY MEDICINE MARKET SIZE, BY ANTIVIRALS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 192. GLOBAL VETERINARY MEDICINE MARKET SIZE, BY ANTIVIRALS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 193. GLOBAL VETERINARY MEDICINE MARKET SIZE, BY ANTIVIRALS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 194. GLOBAL VETERINARY MEDICINE MARKET SIZE, BY ANTIVIRALS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 195. GLOBAL VETERINARY MEDICINE MARKET SIZE, BY ANTI INFLAMMATORIES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 196. GLOBAL VETERINARY MEDICINE MARKET SIZE, BY ANTI INFLAMMATORIES, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 197. GLOBAL VETERINARY MEDICINE MARKET SIZE, BY ANTI INFLAMMATORIES, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 198. GLOBAL VETERINARY MEDICINE MARKET SIZE, BY ANTI INFLAMMATORIES, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 199. GLOBAL VETERINARY MEDICINE MARKET SIZE, BY ANTI INFLAMMATORIES, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 200. GLOBAL VETERINARY MEDICINE MARKET SIZE, BY ANTI INFLAMMATORIES, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 201. GLOBAL VETERINARY MEDICINE MARKET SIZE, BY CARDIOVASCULAR, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 202. GLOBAL VETERINARY MEDICINE MARKET SIZE, BY CARDIOVASCULAR, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 203. GLOBAL VETERINARY MEDICINE MARKET SIZE, BY CARDIOVASCULAR, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 204. GLOBAL VETERINARY MEDICINE MARKET SIZE, BY CARDIOVASCULAR, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 205. GLOBAL VETERINARY MEDICINE MARKET SIZE, BY CARDIOVASCULAR, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 206. GLOBAL VETERINARY MEDICINE MARKET SIZE, BY CARDIOVASCULAR, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 207. GLOBAL VETERINARY MEDICINE MARKET SIZE, BY PARASITICIDES, 2018-2024 (USD MILLION)
  • TABLE 208. GLOBAL VETERINARY MEDICINE MARKET SIZE, BY PARASITICIDES, 2025-2032 (USD MILLION)
  • TABLE 209. GLOBAL VETERINARY MEDICINE MARKET SIZE, BY PARASITICIDES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 210. GLOBAL VETERINARY MEDICINE MARKET SIZE, BY PARASITICIDES, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 211. GLOBAL VETERINARY MEDICINE MARKET SIZE, BY PARASITICIDES, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 212. GLOBAL VETERINARY MEDICINE MARKET SIZE, BY PARASITICIDES, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 213. GLOBAL VETERINARY MEDICINE MARKET SIZE, BY PARASITICIDES, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 214. GLOBAL VETERINARY MEDICINE MARKET SIZE, BY PARASITICIDES, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 215. GLOBAL VETERINARY MEDICINE MARKET SIZE, BY ECTOPARASITICIDES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 216. GLOBAL VETERINARY MEDICINE MARKET SIZE, BY ECTOPARASITICIDES, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 217. GLOBAL VETERINARY MEDICINE MARKET SIZE, BY ECTOPARASITICIDES, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 218. GLOBAL VETERINARY MEDICINE MARKET SIZE, BY ECTOPARASITICIDES, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 219. GLOBAL VETERINARY MEDICINE MARKET SIZE, BY ECTOPARASITICIDES, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 220. GLOBAL VETERINARY MEDICINE MARKET SIZE, BY ECTOPARASITICIDES, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 221. GLOBAL VETERINARY MEDICINE MARKET SIZE, BY ENDECTOCIDES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 222. GLOBAL VETERINARY MEDICINE MARKET SIZE, BY ENDECTOCIDES, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 223. GLOBAL VETERINARY MEDICINE MARKET SIZE, BY ENDECTOCIDES, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 224. GLOBAL VETERINARY MEDICINE MARKET SIZE, BY ENDECTOCIDES, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 225. GLOBAL VETERINARY MEDICINE MARKET SIZE, BY ENDECTOCIDES, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 226. GLOBAL VETERINARY MEDICINE MARKET SIZE, BY ENDECTOCIDES, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 227. GLOBAL VETERINARY MEDICINE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
  • TABLE 228. GLOBAL VETERINARY MEDICINE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2032 (USD MILLION)
  • TABLE 229. GLOBAL VETERINARY MEDICINE MARKET SIZE, BY INHALATION, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 230. GLOBAL VETERINARY MEDICINE MARKET SIZE, BY INHALATION, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 231. GLOBAL VETERINARY MEDICINE MARKET SIZE, BY INHALATION, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 232. GLOBAL VETERINARY MEDICINE MARKET SIZE, BY INHALATION, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 233. GLOBAL VETERINARY MEDICINE MARKET SIZE, BY INHALATION, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 234. GLOBAL VETERINARY MEDICINE MARKET SIZE, BY INHALATION, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 235. GLOBAL VETERINARY MEDICINE MARKET SIZE, BY INJECTABLE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 236. GLOBAL VETERINARY MEDICINE MARKET SIZE, BY INJECTABLE, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 237. GLOBAL VETERINARY MEDICINE MARKET SIZE, BY INJECTABLE, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 238. GLOBAL VETERINARY MEDICINE MARKET SIZE, BY INJECTABLE, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 239. GLOBAL VETERINARY MEDICINE MARKET SIZE, BY INJECTABLE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 240. GLOBAL VETERINARY MEDICINE MARKET SIZE, BY INJECTABLE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 241. GLOBAL VETERINARY MEDICINE MARKET SIZE, BY ORAL, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 242. GLOBAL VETERINARY MEDICINE MARKET SIZE, BY ORAL, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 243. GLOBAL VETERINARY MEDICINE MARKET SIZE, BY ORAL, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 244. GLOBAL VETERINARY MEDICINE MARKET SIZE, BY ORAL, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 245. GLOBAL VETERINARY MEDICINE MARKET SIZE, BY ORAL, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 246. GLOBAL VETERINARY MEDICINE MARKET SIZE, BY ORAL, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 247. GLOBAL VETERINARY MEDICINE MARKET SIZE, BY TOPICAL, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 248. GLOBAL VETERINARY MEDICINE MARKET SIZE, BY TOPICAL, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 249. GLOBAL VETERINARY MEDICINE MARKET SIZE, BY TOPICAL, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 250. GLOBAL VETERINARY MEDICINE MARKET SIZE, BY TOPICAL, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 251. GLOBAL VETERINARY MEDICINE MARKET SIZE, BY TOPICAL, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 252. GLOBAL VETERINARY MEDICINE MARKET SIZE, BY TOPICAL, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 253. GLOBAL VETERINARY MEDICINE MARKET SIZE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 254. GLOBAL VETERINARY MEDICINE MARKET SIZE, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 255. AMERICAS VETERINARY MEDICINE MARKET SIZE, BY SUBREGION, 2018-2024 (USD MILLION)
  • TABLE 256. AMERICAS VETERINARY MEDICINE MARKET SIZE, BY SUBREGION, 2025-2032 (USD MILLION)
  • TABLE 257. AMERICAS VETERINARY MEDICINE MARKET SIZE, BY ANIMAL TYPE, 2018-2024 (USD MILLION)
  • TABLE 258. AMERICAS VETERINARY MEDICINE MARKET SIZE, BY ANIMAL TYPE, 2025-2032 (USD MILLION)
  • TABLE 259. AMERICAS VETERINARY MEDICINE MARKET SIZE, BY COMPANION ANIMAL, 2018-2024 (USD MILLION)
  • TABLE 260. AMERICAS VETERINARY MEDICINE MARKET SIZE, BY COMPANION ANIMAL, 2025-2032 (USD MILLION)
  • TABLE 261. AMERICAS VETERINARY MEDICINE MARKET SIZE, BY EQUINE, 2018-2024 (USD MILLION)
  • TABLE 262. AMERICAS VETERINARY MEDICINE MARKET SIZE, BY EQUINE, 2025-2032 (USD MILLION)
  • TABLE 263. AMERICAS VETERINARY MEDICINE MARKET SIZE, BY LIVESTOCK, 2018-2024 (USD MILLION)
  • TABLE 264. AMERICAS VETERINARY MEDICINE MARKET SIZE, BY LIVESTOCK, 2025-2032 (USD MILLION)
  • TABLE 265. AMERICAS VETERINARY MEDICINE MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 266. AMERICAS VETERINARY MEDICINE MARKET SIZE, BY PRODUCT TYPE, 2025-2032 (USD MILLION)
  • TABLE 267. AMERICAS VETERINARY MEDICINE MARKET SIZE, BY DIAGNOSTICS, 2018-2024 (USD MILLION)
  • TABLE 268. AMERICAS VETERINARY MEDICINE MARKET SIZE, BY DIAGNOSTICS, 2025-2032 (USD MILLION)
  • TABLE 269. AMERICAS VETERINARY MEDICINE MARKET SIZE, BY PHARMACEUTICALS, 2018-2024 (USD MILLION)
  • TABLE 270. AMERICAS VETERINARY MEDICINE MARKET SIZE, BY PHARMACEUTICALS, 2025-2032 (USD MILLION)
  • TABLE 271. AMERICAS VETERINARY MEDICINE MARKET SIZE, BY VACCINES, 2018-2024 (USD MILLION)
  • TABLE 272. AMERICAS VETERINARY MEDICINE MARKET SIZE, BY VACCINES, 2025-2032 (USD MILLION)
  • TABLE 273. AMERICAS VETERINARY MEDICINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
  • TABLE 274. AMERICAS VETERINARY MEDICINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2032 (USD MILLION)
  • TABLE 275. AMERICAS VETERINARY MEDICINE MARKET SIZE, BY THERAPEUTIC AREA, 2018-2024 (USD MILLION)
  • TABLE 276. AMERICAS VETERINARY MEDICINE MARKET SIZE, BY THERAPEUTIC AREA, 2025-2032 (USD MILLION)
  • TABLE 277. AMERICAS VETERINARY MEDICINE MARKET SIZE, BY ANTI INFECTIVES, 2018-2024 (USD MILLION)
  • TABLE 278. AMERICAS VETERINARY MEDICINE MARKET SIZE, BY ANTI INFECTIVES, 2025-2032 (USD MILLION)
  • TABLE 279. AMERICAS VETERINARY MEDICINE MARKET SIZE, BY PARASITICIDES, 2018-2024 (USD MILLION)
  • TABLE 280. AMERICAS VETERINARY MEDICINE MARKET SIZE, BY PARASITICIDES, 2025-2032 (USD MILLION)
  • TABLE 281. AMERICAS VETERINARY MEDICINE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
  • TABLE 282. AMERICAS VETERINARY MEDICINE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2032 (USD MILLION)
  • TABLE 283. NORTH AMERICA VETERINARY MEDICINE MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 284. NORTH AMERICA VETERINARY MEDICINE MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 285. NORTH AMERICA VETERINARY MEDICINE MARKET SIZE, BY ANIMAL TYPE, 2018-2024 (USD MILLION)
  • TABLE 286. NORTH AMERICA VETERINARY MEDICINE MARKET SIZE, BY ANIMAL TYPE, 2025-2032 (USD MILLION)
  • TABLE 287. NORTH AMERICA VETERINARY MEDICINE MARKET SIZE, BY COMPANION ANIMAL, 2018-2024 (USD MILLION)
  • TABLE 288. NORTH AMERICA VETERINARY MEDICINE MARKET SIZE, BY COMPANION ANIMAL, 2025-2032 (USD MILLION)
  • TABLE 289. NORTH AMERICA VETERINARY MEDICINE MARKET SIZE, BY EQUINE, 2018-2024 (USD MILLION)
  • TABLE 290. NORTH AMERICA VETERINARY MEDICINE MARKET SIZE, BY EQUINE, 2025-2032 (USD MILLION)
  • TABLE 291. NORTH AMERICA VETERINARY MEDICINE MARKET SIZE, BY LIVESTOCK, 2018-2024 (USD MILLION)
  • TABLE 292. NORTH AMERICA VETERINARY MEDICINE MARKET SIZE, BY LIVESTOCK, 2025-2032 (USD MILLION)
  • TABLE 293. NORTH AMERICA VETERINARY MEDICINE MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 294. NORTH AMERICA VETERINARY MEDICINE MARKET SIZE, BY PRODUCT TYPE, 2025-2032 (USD MILLION)
  • TABLE 295. NORTH AMERICA VETERINARY MEDICINE MARKET SIZE, BY DIAGNOSTICS, 2018-2024 (USD MILLION)
  • TABLE 296. NORTH AMERICA VETERINARY MEDICINE MARKET SIZE, BY DIAGNOSTICS, 2025-2032 (USD MILLION)
  • TABLE 297. NORTH AMERICA VETERINARY MEDICINE MARKET SIZE, BY PHARMACEUTICALS, 2018-2024 (USD MILLION)
  • TABLE 298. NORTH AMERICA VETERINARY MEDICINE MARKET SIZE, BY PHARMACEUTICALS, 2025-2032 (USD MILLION)
  • TABLE 299. NORTH AMERICA VETERINARY MEDICINE MARKET SIZE, BY VACCINES, 2018-2024 (USD MILLION)
  • TABLE 300. NORTH AMERICA VETERINARY MEDICINE MARKET SIZE, BY VACCINES, 2025-2032 (USD MILLION)
  • TABLE 301. NORTH AMERICA VETERINARY MEDICINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
  • TABLE 302. NORTH AMERICA VETERINARY MEDICINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2032 (USD MILLION)
  • TABLE 303. NORTH AMERICA VETERINARY MEDICINE MARKET SIZE, BY THERAPEUTIC AREA, 2018-2024 (USD MILLION)
  • TABLE 304. NORTH AMERICA VETERINARY MEDICINE MARKET SIZE, BY THERAPEUTIC AREA, 2025-2032 (USD MILLION)
  • TABLE 305. NORTH AMERICA VETERINARY MEDICINE MARKET SIZE, BY ANTI INFECTIVES, 2018-2024 (USD MILLION)
  • TABLE 306. NORTH AMERICA VETERINARY MEDICINE MARKET SIZE, BY ANTI INFECTIVES, 2025-2032 (USD MILLION)
  • TABLE 307. NORTH AMERICA VETERINARY MEDICINE MARKET SIZE, BY PARASITICIDES, 2018-2024 (USD MILLION)
  • TABLE 308. NORTH AMERICA VETERINARY MEDICINE MARKET SIZE, BY PARASITICIDES, 2025-2032 (USD MILLION)
  • TABLE 309. NORTH AMERICA VETERINARY MEDICINE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
  • TABLE 310. NORTH AMERICA VETERINARY MEDICINE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2032 (USD MILLION)
  • TABLE 311. LATIN AMERICA VETERINARY MEDICINE MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 312. LATIN AMERICA VETERINARY MEDICINE MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 313. LATIN AMERICA VETERINARY MEDICINE MARKET SIZE, BY ANIMAL TYPE, 2018-2024 (USD MILLION)
  • TABLE 314. LATIN AMERICA VETERINARY MEDICINE MARKET SIZE, BY ANIMAL TYPE, 2025-2032 (USD MILLION)
  • TABLE 315. LATIN AMERICA VETERINARY MEDICINE MARKET SIZE, BY COMPANION ANIMAL, 2018-2024 (USD MILLION)
  • TABLE 316. LATIN AMERICA VETERINARY MEDICINE MARKET SIZE, BY COMPANION ANIMAL, 2025-2032 (USD MILLION)
  • TABLE 317. LATIN AMERICA VETERINARY MEDICINE MARKET SIZE, BY EQUINE, 2018-2024 (USD MILLION)
  • TABLE 318. LATIN AMERICA VETERINARY MEDICINE MARKET SIZE, BY EQUINE, 2025-2032 (USD MILLION)
  • TABLE 319. LATIN AMERICA VETERINARY MEDICINE MARKET SIZE, BY LIVESTOCK, 2018-2024 (USD MILLION)
  • TABLE 320. LATIN AMERICA VETERINARY MEDICINE MARKET SIZE, BY LIVESTOCK, 2025-2032 (USD MILLION)
  • TABLE 321. LATIN AMERICA VETERINARY MEDICINE MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 322. LATIN AMERICA VETERINARY MEDICINE MARKET SIZE, BY PRODUCT TYPE, 2025-2032 (USD MILLION)
  • TABLE 323. LATIN AMERICA VETERINARY MEDICINE MARKET SIZE, BY DIAGNOSTICS, 2018-2024 (USD MILLION)
  • TABLE 324. LATIN AMERICA VETERINARY MEDICINE MARKET SIZE, BY DIAGNOSTICS, 2025-2032 (USD MILLION)
  • TABLE 325. LATIN AMERICA VETERINARY MEDICINE MARKET SIZE, BY PHARMACEUTICALS, 2018-2024 (USD MILLION)
  • TABLE 326. LATIN AMERICA VETERINARY MEDICINE MARKET SIZE, BY PHARMACEUTICALS, 2025-2032 (USD MILLION)
  • TABLE 327. LATIN AMERICA VETERINARY MEDICINE MARKET SIZE, BY VACCINES, 2018-2024 (USD MILLION)
  • TABLE 328. LATIN AMERICA VETERINARY MEDICINE MARKET SIZE, BY VACCINES, 2025-2032 (USD MILLION)
  • TABLE 329. LATIN A